Trials / Active Not Recruiting
Active Not RecruitingNCT05515809
Evaluation of the Effect of Para-sternal Block on Postoperative Respiratory Function After Cardiac Sternotomy Surgery
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative pain after cardiac surgery is associated with reduced postoperative respiratory function. There is an association between greater pain and more pronounced decreases in lung volumes postoperatively. With an incidence of 10% to 25% of cases, pulmonary complications are the second source of postoperative morbidity after cardiac complications; in 2-5% of cases, the dysfunction is severe and leads to significant consequences that can lead to death. It has been shown that postoperative pain after cardiac surgery is associated with a reduction in functional respiratory capacity. There is an association between greater pain and more pronounced decreases in lung volumes postoperatively. The main objective of this study will be to evaluate the impact of locoregional anesthesia by parasternal block analgesic on postoperative respiratory function at D1 postoperatively
Conditions
- Cardiac Surgery
- Ultrasound-guided Parasternal Block
- Postoperative Pulmonary Complications
- Pulmonary Function Testing
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | parasternal block | Echo-guided loco-regional anesthesia by bilateral parasternal block in immediate preoperative. The drug used is Ropivacaine 2mg/ml, 0.2%. Injection of 20ml per side, under ultrasound control, after general anaesthesia and before skin incision, and therefore before surgery |
| DRUG | Standard pain management | Standard pain management care involves a multimodal strategy that includes the use of intravenous analgesics. Morphine medications are the mainstay of pain management |
Timeline
- Start date
- 2022-07-19
- Primary completion
- 2025-06-01
- Completion
- 2025-06-01
- First posted
- 2022-08-25
- Last updated
- 2025-05-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05515809. Inclusion in this directory is not an endorsement.